Cargando…
Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression
BACKGROUND: BK nephropathy (BKN) affects graft function and increases the risk of graft failure. The reduction of immunosuppression is the main treatment for BKN. However, acute rejection may develop following immunosuppression reduction, and data regarding the risk factors of acute rejection during...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248279/ https://www.ncbi.nlm.nih.gov/pubmed/30297686 http://dx.doi.org/10.12659/AOT.910483 |
_version_ | 1783372609832878080 |
---|---|
author | Baek, Chung Hee Kim, Hyosang Yu, Hoon Yang, Won Seok Han, Duck Jong Park, Su-Kil |
author_facet | Baek, Chung Hee Kim, Hyosang Yu, Hoon Yang, Won Seok Han, Duck Jong Park, Su-Kil |
author_sort | Baek, Chung Hee |
collection | PubMed |
description | BACKGROUND: BK nephropathy (BKN) affects graft function and increases the risk of graft failure. The reduction of immunosuppression is the main treatment for BKN. However, acute rejection may develop following immunosuppression reduction, and data regarding the risk factors of acute rejection during the post-reduction period are insufficient. MATERIAL/METHODS: Of 758 patients who received a kidney transplantation (KT) between 2008 and 2011, 79 who underwent immunosuppression reduction as BKN treatment were enrolled. The risk factors of acute rejection after immunosuppression reduction were identified using multivariate logistic regression analysis. RESULTS: During the median follow-up period (75 months), acute rejection developed in 21.5% of study group patients and in 22.5% of KT recipients without BKN. The rejection group showed a trend of higher body mass index (24.13±3.92 vs. 22.40±3.31 kg/m(2), P=0.070) and lower tacrolimus levels than the no rejection group, although mycophenolate mofetil (MMF) doses were not lower in the rejection group. The rejection group showed worse graft survival than the no rejection group (P=0.001 by the log rank test). A greater number of patients in the rejection group exhibited reduced calcineurin inhibitor (CNI) level by >20% at 1 month after initial BKV detection (34.2% vs. 7.9%, P=0.008). Multivariate analysis indicated that the peak BKV PCR level (odds ratio [OR], 0.136; 95% confidence interval [CI], 0.025–0.732; P=0.020), MMF discontinuation (vs. MMF reduction; OR, 0.112; 95% CI, 0.020–0.618; P=0.012) and CNI level reduction >20% (OR, 33.752; 95% CI, 4.263–267.251; P=0.001) were significantly associated with acute rejection. CONCLUSIONS: Acute rejection after immunosuppression reduction for BKN showed worse allograft survival than the patients without acute rejection. In addition, a CNI dose reduction >20% at 1 month after the initial BKV detection can increase the risk of acute rejection. |
format | Online Article Text |
id | pubmed-6248279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62482792018-11-28 Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression Baek, Chung Hee Kim, Hyosang Yu, Hoon Yang, Won Seok Han, Duck Jong Park, Su-Kil Ann Transplant Original Paper BACKGROUND: BK nephropathy (BKN) affects graft function and increases the risk of graft failure. The reduction of immunosuppression is the main treatment for BKN. However, acute rejection may develop following immunosuppression reduction, and data regarding the risk factors of acute rejection during the post-reduction period are insufficient. MATERIAL/METHODS: Of 758 patients who received a kidney transplantation (KT) between 2008 and 2011, 79 who underwent immunosuppression reduction as BKN treatment were enrolled. The risk factors of acute rejection after immunosuppression reduction were identified using multivariate logistic regression analysis. RESULTS: During the median follow-up period (75 months), acute rejection developed in 21.5% of study group patients and in 22.5% of KT recipients without BKN. The rejection group showed a trend of higher body mass index (24.13±3.92 vs. 22.40±3.31 kg/m(2), P=0.070) and lower tacrolimus levels than the no rejection group, although mycophenolate mofetil (MMF) doses were not lower in the rejection group. The rejection group showed worse graft survival than the no rejection group (P=0.001 by the log rank test). A greater number of patients in the rejection group exhibited reduced calcineurin inhibitor (CNI) level by >20% at 1 month after initial BKV detection (34.2% vs. 7.9%, P=0.008). Multivariate analysis indicated that the peak BKV PCR level (odds ratio [OR], 0.136; 95% confidence interval [CI], 0.025–0.732; P=0.020), MMF discontinuation (vs. MMF reduction; OR, 0.112; 95% CI, 0.020–0.618; P=0.012) and CNI level reduction >20% (OR, 33.752; 95% CI, 4.263–267.251; P=0.001) were significantly associated with acute rejection. CONCLUSIONS: Acute rejection after immunosuppression reduction for BKN showed worse allograft survival than the patients without acute rejection. In addition, a CNI dose reduction >20% at 1 month after the initial BKV detection can increase the risk of acute rejection. International Scientific Literature, Inc. 2018-10-09 /pmc/articles/PMC6248279/ /pubmed/30297686 http://dx.doi.org/10.12659/AOT.910483 Text en © Ann Transplant, 2018 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Original Paper Baek, Chung Hee Kim, Hyosang Yu, Hoon Yang, Won Seok Han, Duck Jong Park, Su-Kil Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression |
title | Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression |
title_full | Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression |
title_fullStr | Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression |
title_full_unstemmed | Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression |
title_short | Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression |
title_sort | risk factors of acute rejection in patients with bk nephropathy after reduction of immunosuppression |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248279/ https://www.ncbi.nlm.nih.gov/pubmed/30297686 http://dx.doi.org/10.12659/AOT.910483 |
work_keys_str_mv | AT baekchunghee riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression AT kimhyosang riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression AT yuhoon riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression AT yangwonseok riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression AT handuckjong riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression AT parksukil riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression |